M A Corporate Development

MARTIN DOYLE

******.*****.*****@*****.*** 650-***-**** www.linkedin.com/in/martin-doyle-mba

SUMMARY

Life Sciences Executive with 20 years of experience driving M&A, strategic partnerships, and commercial growth across top- tier companies including Applied Biosystems, Life Technologies, ThermoFisher, and Esco Lifesciences. A proven leader in global corporate development, known for identifying high-impact opportunities, executing complex acquisitions, and delivering integration strategies that unlock value. Spearheaded business, product, and commercial development for a pioneering nanopore sequencing start-up targeting multi-billion-dollar genomics and proteomics markets. Thrive in dynamic, high-growth environments—bringing strategic clarity, deal-making rigor, and operational execution to cutting- edge life science innovation. Passionate about advancing precision technologies, scaling global platforms, and shaping the future of biotech through smart, strategic growth. PROFESSIONAL EXPERIENCE

ESCO LIFESCIENCES GROUP, Singapore (Remote – San Francisco Bay Area) Head of M&A and Corporate Development 2023 – Present Esco Lifesciences is a global life sciences company with 1,500+ employees and seven operational sites worldwide, providing equipment and solutions to research, IVF, and pharmaceutical manufacturing markets.

• Built and led Esco’s corporate development function from the ground up, establishing an end-to-end M&A infrastructure—developing robust target funnels, investment theses, valuation models, and board-level deal recommendations.

• Sourced, evaluated, and executed global M&A transactions, overseeing the full lifecycle including strategic fit assessment, financial and operational due diligence, legal negotiation, and post-merger integration planning.

• Closed key strategic acquisition that significantly expanded Esco’s presence in the IVF market—directly contributing to double-digit revenue growth and strengthening of the business unit’s financial standing.

• Directed all business development activities, including in-licensing agreements, commercial partnerships, co-marketing initiatives, and cross-border joint ventures, resulting in expanded business opportunities and enhanced customer reach.

• Served as a key advisor to the CEO and executive team on corporate strategy, investment priorities, and organizational growth, influencing decisions across all three core business units.

• Led transformational corporate initiatives including organizational restructuring, operating model redesign, and cross- functional synergy capture—streamlining global operations and driving cost optimization. QUANTAPORE INC. South San Francisco, CA

COO and VP of Commercialization and Business Development 2019 – 2022 VC-backed biotech startup pioneering single-molecule nanopore sequencing technology to advance long-read DNA/RNA analysis and protein fingerprinting.

• Led the transition from R&D to commercial-stage operations, architecting corporate strategy, product development roadmaps, and operational infrastructure that positioned Quantapore for market readiness and investor validation.

• Designed and executed the company’s go-to-market strategy, including customer segmentation, competitive analysis, and pricing frameworks—strengthening the company’s market positioning within the rapidly evolving genomics landscape.

• Directed company-wide operations as COO, including HR, compliance, and facilities management—establishing scalable systems and processes to support future growth.

• Spearheaded business development initiatives, identifying and negotiating strategic partnerships, licensing opportunities, and early customer engagements to build pipeline traction and scientific credibility.

• Co-led capital fundraising strategy and investor relations, resulting in successful insider-led funding rounds that extended operational runway and enabled continued technology development during a critical growth phase.

• Collaborated closely with scientific leadership to align product design with market needs, bridging technical innovation with commercial viability and helping accelerate time-to-proof-of-concept. RESOURCES GLOBAL PROFESSIONALS Santa Clara, CA

Sr. Consultant – M&A and Integration 2016–2018

Publicly traded consulting firm ($620M+ market cap) delivering global advisory services in finance, mergers & acquisitions, and post-deal integration.

• Program managed integration of a $1.4B acquisition in the Internet of Things (IoT) sector, aligning cross-functional workstreams across operations, finance, IT, and HR to ensure seamless onboarding and synergy capture—delivering integration milestones on schedule and under budget.

• Directed post-merger integration of an app development firm, standardizing tools and systems while preserving innovation culture; successfully minimized employee attrition and accelerated time-to-market for product launches.

• Supported the formation of a strategic joint venture between Cisco and a China-based networking company, advising on corporate structure, governance frameworks, and cross-border compliance considerations—helping to establish a scalable operational model in a complex regulatory environment.

• Partnered with executive stakeholders to identify operational risks and drive value realization plans, facilitating smoother transitions and maximizing long-term acquisition value. APPLIED BIOSYSTEMS / LIFE TECHNOLOGIES / THERMO FISHER, CA 2002 - 2015

$14B+ market cap, publicly traded life sciences company delivering advanced analytical instruments, diagnostics, and reagents to researchers and clinicians worldwide.

Senior Integration & Business Transformation Leader

• Drove post-merger integration and division-building initiatives that enabled the company’s strategic entry into the

$36B+ molecular diagnostics market.

• Established the foundation of the Molecular Diagnostics division by integrating multiple acquired entities into a unified business unit—establishing a scalable foundation that accelerated market entry and long-term growth.

• Led a global, cross-functional team of 50+ professionals across operations, IT, finance, commercial, and R&D, ensuring alignment on post-deal execution, infrastructure, and cultural integration.

• Designed and implemented the business and system infrastructure (ERP, CRM, reporting, governance) to support ongoing operations, regulatory compliance, and product development.

• Partnered directly with C-level executives to execute integration strategies, track synergy realization, and mitigate risks to acquisition value during complex transitional phases. Corporate Development – Mergers & Acquisitions Leader

• Championed strategic growth initiatives through end-to-end M&A execution and portfolio expansion.

• Developed and executed inorganic growth strategies to penetrate new markets and expand capabilities, including identifying white space opportunities and aligning deals with long-term strategic priorities.

• Led cross-functional due diligence teams, including finance, legal, R&D, commercial, and regulatory experts— successfully closing multiple high-impact transactions that enhanced the company’s global footprint.

• Negotiated key deal terms in collaboration with legal and investment banking partners, balancing risk mitigation with value creation.

• Served as strategic advisor to integration leads, translating deal rationale into actionable integration plans to preserve and maximize deal value.

Business Operations – Product Portfolio Management Leader

• Oversaw the financial and operational health of a $900M product portfolio within the Genetic Systems division.

• Directed resource allocation and budgeting for a 300+ person global R&D team, ensuring efficient deployment of talent and capital across development priorities.

• Provided strategic oversight for new product development, aligning innovation efforts with market demand and revenue growth targets.

• Managed lifecycle planning for key products, guiding investment decisions, product sunsets, and pipeline prioritization to drive sustainable portfolio performance.

Business & Corporate Development – M&A, Licensing, and Strategy

• Led the company’s M&A and licensing infrastructure as part of a lean, high-impact corporate development team.

• Completed two transformative acquisitions, expanding the company’s capabilities in adjacent markets and enabling new revenue streams.

• Chaired a global technology in-licensing initiative, identifying critical intellectual property and third-party technologies to enhance internal innovation.

• Built and institutionalized M&A practices, including deal evaluation frameworks, governance models, and cross- functional coordination protocols.

EDUCATION

GEORGETOWN UNIVERSITY

McDonough School of Business

Master's in Business

Administration

UNIVERSITY OF CALIFORNIA

at Davis

Master of Science – Plant Cell &

Molecular Biology

UNIVERSITY OF CALIFORNIA

at Santa Barbara

Bachelor of Arts – Plant Cell &

Molecular Biology

SKILLS

Mergers & Acquisitions Execution Post-Merger Integration Strategy Strategic Market Entry Business Transformation Leadership Joint Ventures & Strategic Partnerships Product Portfolio Management Go-to-Market Strategy Cross- Functional Team Leadership Organizational Design & Scaling Financial & Operational Due Diligence Technology Commercialization Licensing & IP Strategy Capital Fundraising & Investor Relations C-Suite & Board Advisory Global Business Acumen Growth Strategy Synergy Realization & Value Capture Regulatory & Compliance Strategy Corporate Development Infrastructure

Contact this candidate